Parkinson’s disease has no cure, but a combination of medications, surgical options, and lifestyle strategies can significantly control symptoms and maintain quality of life for years. Treatment typically starts with medication and evolves over time as the disease progresses, with adjustments tailored to each person’s specific symptoms and response.
Levodopa: The Primary Medication
Levodopa remains the most effective drug for managing Parkinson’s motor symptoms, even decades after its introduction. It works as a building block that your brain converts into dopamine, the chemical messenger that Parkinson’s gradually destroys. The challenge is that your body breaks down levodopa before it ever reaches the brain, so it’s always paired with carbidopa, a companion drug that blocks that premature breakdown and lets more levodopa get where it’s needed.
Treatment typically starts at a low dose of one tablet three times a day and is gradually increased based on how well symptoms respond. Most people notice meaningful improvement in stiffness, slowness, and tremor. Over time, though, levodopa’s effects can become less predictable. Many people experience “off” periods where the medication wears off before the next dose, alternating with “on” periods of good symptom control. This wearing-off pattern is one of the central challenges of long-term Parkinson’s management and often drives decisions about adding other medications or considering surgery.
Other Medications That Help
Several drug classes work alongside or instead of levodopa, depending on the stage of disease and which symptoms are most bothersome.
Dopamine agonists mimic dopamine’s effects in the brain rather than converting into it. Common options include ropinirole and rotigotine (a skin patch). These are sometimes used as a first treatment in younger patients or added later to smooth out fluctuations. They tend to cause more side effects than levodopa, including drowsiness, nausea, and in some cases compulsive behaviors like gambling or overeating.
MAO-B inhibitors take a different approach: they slow the enzyme that breaks down dopamine in the brain, making whatever dopamine is available last longer. Options include selegiline, rasagiline, and safinamide. When used with levodopa, these drugs can extend the “on” time and reduce the frustrating gaps when medication wears off. Some people use them as an early, mild treatment on their own before starting levodopa.
Other medications in the toolkit include COMT inhibitors, which extend levodopa’s duration in the bloodstream, and anticholinergics, which primarily help with tremor. Your neurologist will layer these medications based on which symptoms are most disruptive and how your body responds.
Deep Brain Stimulation
Deep brain stimulation (DBS) is the most established surgical treatment for Parkinson’s. It involves implanting thin electrodes in specific areas of the brain, connected to a small pulse generator placed under the skin near the collarbone. The device sends continuous electrical signals that interrupt the faulty brain circuits causing motor symptoms.
DBS is not for everyone, and timing matters. The best candidates have had Parkinson’s for five years or more, still respond well to levodopa, experience disabling tremors or involuntary movements (dyskinesia), and deal with severe motor fluctuations that medication adjustments can’t control. This last point is key: DBS works best in people whose symptoms still improve with levodopa but who can’t maintain consistent control throughout the day.
People with significant cognitive decline, untreated depression, or atypical forms of Parkinson’s are generally not good candidates. Neuropsychological testing is standard before surgery to evaluate memory and thinking abilities. A strong support network also matters, since learning to manage and adjust the DBS system takes time and follow-up visits. When medications stop working entirely, DBS typically won’t help either, since it works by optimizing the same brain pathways that levodopa targets.
Focused Ultrasound for Tremor
For people whose primary problem is tremor, MR-guided focused ultrasound offers a newer, incisionless option. The procedure uses concentrated sound waves guided by MRI to create a tiny, precise lesion in the brain area responsible for tremor. There’s no surgery, no implanted hardware, and patients are awake during the procedure.
In the clinical trial that led to FDA approval, patients reported a 62% median improvement in hand tremor three months after treatment. The most common side effects are mild and often temporary: nausea, headache during the procedure, numbness or tingling in the fingertips or lips, and some unsteadiness with walking or balance. Speech and swallowing issues can also occur temporarily. The procedure currently treats one side of the body at a time, so it’s best suited for people with tremor that predominantly affects one hand.
Exercise and Physical Therapy
Exercise is one of the few interventions shown to potentially slow the progression of Parkinson’s symptoms, not just manage them. Aerobic exercise, strength training, and balance work all play distinct roles. Consistent moderate-to-vigorous exercise (cycling, brisk walking, swimming) several times a week improves mobility, reduces stiffness, and helps with mood and sleep.
Specialized physical therapy programs designed for Parkinson’s focus on retraining movement patterns that the disease disrupts. These programs emphasize big, exaggerated movements to counteract the tendency toward smaller, shuffling steps and reduced arm swing. The goal is to recalibrate your sense of how much effort a movement requires, since Parkinson’s causes people to underestimate their own movement size. Occupational therapy can also help with fine motor tasks like buttoning clothes or using utensils, while speech therapy addresses the vocal softness and swallowing difficulties that often develop.
Managing Non-Motor Symptoms
Parkinson’s is far more than a movement disorder. Most people experience a range of non-motor symptoms that can be just as disruptive as tremor or stiffness, including sleep disturbances, mood changes, constipation, blood pressure drops, and in later stages, hallucinations or psychosis.
Sleep problems are especially common. Many people with Parkinson’s develop REM sleep behavior disorder, where they physically act out vivid dreams by kicking, punching, or yelling during sleep. Low-dose melatonin is often tried first, sometimes combined with other sedating medications. Orthostatic hypotension, a sudden drop in blood pressure when standing up, affects many people and causes dizziness or fainting. Practical strategies like standing up slowly, increasing fluid and salt intake, and wearing compression stockings help. Medications that raise blood pressure can also be used short-term when lifestyle measures aren’t enough.
Hallucinations and psychosis can develop in later stages, sometimes triggered by the very medications used to treat motor symptoms. When hallucinations become distressing or affect safety, specific antipsychotic medications that don’t worsen Parkinson’s motor symptoms can be effective. Not all antipsychotics are safe for Parkinson’s patients, so this requires careful selection by a specialist.
Protein and Medication Timing
Protein in food competes with levodopa for absorption in the gut and transport into the brain, which means a high-protein meal taken at the wrong time can blunt the medication’s effect. Some people notice their levodopa works less well after eating a steak or drinking a protein shake. The standard advice is to take levodopa 30 to 60 minutes before meals or at least an hour after eating, giving the drug a head start on absorption.
That said, this interaction varies widely from person to person. Some people are highly sensitive to protein timing, while others barely notice a difference. Factors like disease severity, age, and how your digestive system functions all play a role. Rather than following a rigid rule, the most practical approach is to pay attention to whether meals seem to affect your medication response, then work with your care team to create a schedule that balances good nutrition with consistent symptom control. Restricting protein too aggressively can lead to malnutrition and muscle loss, which creates its own problems.
How Treatment Evolves Over Time
Parkinson’s treatment is not static. What works in the first year will almost certainly need adjustment by year five or ten. In early stages, a single medication at a low dose may be enough. As the disease progresses, most people need higher doses, additional medications, and more precise timing to maintain the same level of function. The transition from stable medication response to fluctuating “on” and “off” periods is a turning point that often triggers a reassessment of the entire treatment plan.
At that stage, options expand: adding MAO-B inhibitors or COMT inhibitors to extend each dose, switching to extended-release formulations, considering DBS, or exploring infusion therapies that deliver medication continuously rather than in peaks and valleys. Each adjustment is a balancing act between maximizing symptom control and minimizing side effects like dyskinesia, drowsiness, or impulsive behavior. Regular follow-up with a movement disorder specialist, ideally every three to six months, helps keep the treatment plan aligned with how the disease is actually behaving.